Replacing habitual artificial sweetened beverage intake with water does not improve glycemic outcomes or HbA1c levels in patients with T2D.

In this study from ASCO GI 2026, researchers presented a 4-year follow-up of the phase 3 CheckMate 9DW trial of nivolumab plus ipilimumab in treatment-naïve HCC.

The FDA's policy regarding mifepristone aligned with recommendations made by the agency’s scientists from 2011 to 2023.

Higher antibody response toward Lachnospiraceae flagellin was associated with risk for CD among first-degree relatives of patients with CD.

Patients with colorectal cancer who walked as exercise after their diagnosis reported cancer-related fatigue and higher quality-of-life.

The adverse effects of P-CABs are comparable to PPIs. However, it is important to monitor for hypergastrinemia and hepatic dysfunction.

The response to first advanced treatment initiated is significantly associated with a lower long-term risk for hospitalization.

The first oral GLP-1 weight-loss pill, which contains semaglutide, became available nationwide Monday, January 5.

Inpatient costs associated with alcohol-associated liver disease (ALD) increased from 2016 to 2019, according to a study in ...

A structured, nurse-led IBD flare pathway incorporating rapid access intestinal ultrasound enabled timely outpatient management, decreased acute care resource use, and more. A clinical care pathway ...

The FDA upgraded the ongoing grated pecorino romano cheese recall to Class I, the FDA's highest risk category.

Pancreatic steatosis (PS) is associated with an increased risk and higher severity of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), according to study results ...